Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a)

References

• Ahmad, K., Balaramnavar, V. M., Baig, M. H., Srivastava, A. K., Khan, S., & Kamal, M. A. (2014). Identification of potent caspase-3 inhibitors for treatment of multi-neurodegenerative diseases using pharmacophore modeling and docking approaches. CNS & Neurological Disorders Drug Targets, 13(8), 1346–1353. https://doi.org/10.2174/1871527313666141023120843
   PubMed Web of Science ®Google Scholar
• Arooj, M., Sakkiah, S., Kim, S., Arulalapperumal, V., & Lee, K. W. (2013). A combination of receptor-based pharmacophore modeling – QM techniques for identification of human chymase inhibitors. PLoS One, 8(4), e63030. https://doi.org/10.1371/journal.pone.0063030
   PubMed Web of Science ®Google Scholar
• Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012). Epigenetic protein families: A new frontier for drug discovery. Nature Reviews Drug Discovery, 11(5), 384–400. https://doi.org/10.1038/nrd3674
   PubMed Web of Science ®Google Scholar
• Baig, M. H., Ahmad, K., Roy, S., Ashraf, J. M., Adil, M., Siddiqui, M. H., Khan, S., Kamal, M. A., Provazník, I., & Choi, I. (2016). Computer aided drug design: success and limitations. Current Pharmaceutical Design, 22(5), 572–581. https://doi.org/10.2174/1381612822666151125000550
   PubMed Web of Science ®Google Scholar
• Banerjee, D. R., Deckard, C. E., Zeng, Y. iii, & Sczepanski, J. T. (2019). Acetylation of the histone H3 tail domain regulates base excision repair on higher-order chromatin structures.Scientific Report, 9, 15972 https://doi.org/10.1038/s41598-019-52340-0
   Google Scholar
• Banerjee, D. R., Deckard, C. E., Elinski, M. B., Buzbee, M. L., Wang, W. W., Batteas, J. D., & Sczepanski, J. T. (2018). Plug-and-play approach for preparing chromatin containing site-specific DNA modifications: The influence of chromatin structure on base excision repair. Journal of the American Chemical Society, 140(26), 8260–8267. https://doi.org/10.1021/jacs.8b04063
   PubMed Web of Science ®Google Scholar
• Bannister, A. J., & Kouzarides, T. (2011). Regulation of chromatin by histone modifications. Cell Research, 21(3), 381–395. https://doi.org/10.1038/cr.2011.22
   PubMed Web of Science ®Google Scholar
• Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007). High-resolution profiling of histone methylations in the human genome. Cell, 129(4), 823–837. https://doi.org/10.1016/j.cell.2007.05.009
   PubMed Web of Science ®Google Scholar
• Berger, S. L., Kouzarides, T., Shiekhattar, R., & Shilatifard, A. (2009). An operational definition of epigenetics: Figure 1. Genes & Development, 23(7), 781–783. https://doi.org/10.1101/gad.1787609
   PubMed Web of Science ®Google Scholar
• Bernstein, B. E., Meissner, A., & Lander, E. S. (2007). The mammalian epigenome. Cell, 128(4), 669–681. https://doi.org/10.1016/j.cell.2007.01.033
   PubMed Web of Science ®Google Scholar
• BIOVIA. (2022). Dassault systèmes. Dassault Systèmes.
   Google Scholar
• Bologa, C. G., Olah, M. M., & Oprea, T. I. (2006). Chemical database preparation for compound acquisition or virtual screening. In Bioinformatics and drug discovery (pp. 375–388). Humana Press. https://doi.org/10.1385/1-59259-964-8:375
   Google Scholar
• Bowers, K. J., Chow, D. E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., Sacerdoti, F. D., Salmon, J. K., Shan, Y., & Shaw, D. E. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters [Paper presentation]. ACM/IEEE SC 2006 Conference (SC’06), IEEE. pp. 43–43. https://doi.org/10.1109/SC.2006.54
   Google Scholar
• Cao, H., Li, L., Yang, D., Zeng, L., Yewei, X., Yu, B., Liao, G., & Chen, J. (2019). Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents. European Journal of Medicinal Chemistry, 179, 537–546. https://doi.org/10.1016/j.ejmech.2019.06.072
   PubMed Web of Science ®Google Scholar
• Chae, Y.-C., Kim, J.-Y., Park, J. W., Kim, K.-B., Oh, H., Lee, K.-H., & Seo, S.-B. (2019). FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer. Nucleic Acids Research, 47(4), 1692–1705. https://doi.org/10.1093/nar/gky1230
   PubMed Web of Science ®Google Scholar
• Chang, Y., Ganesh, T., Horton, J. R., Spannhoff, A., Liu, J., Sun, A., Zhang, X., Bedford, M. T., Shinkai, Y., Snyder, J. P., & Cheng, X. (2010). Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases. Journal of Molecular Biology, 400(1), 1–7. https://doi.org/10.1016/j.jmb.2010.04.048
   PubMed Web of Science ®Google Scholar
• Chang, Y., Zhang, X., Horton, J. R., Upadhyay, A. K., Spannhoff, A., Liu, J., Snyder, J. P., Bedford, M. T., & Cheng, X. (2009). Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294. Nature Structural & Molecular Biology, 16(3), 312–317. https://doi.org/10.1038/nsmb.1560
   PubMed Web of Science ®Google Scholar
• Chen, P.-Y., Tsai, C.-T., Ou, C.-Y., Hsu, W.-T., Jhuo, M.-D., Wu, C.-H., Shih, T.-C., Cheng, T.-H., & Chung, J.-G. (2012). Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H3 receptor antagonists for Alzheimer’s disease by docking, scoring and de novo evolution. Molecular Medicine Reports, 5(4), 1043–1048. https://doi.org/10.3892/mmr.2012.757
   PubMed Web of Science ®Google Scholar
• Cheng, X., Collins, R. E., & Zhang, X. (2005). Structural and sequence motifs of protein (histone) methylation enzymes. Annual Review of Biophysics and Biomolecular Structure, 34, 267–294. https://doi.org/10.1146/annurev.biophys.34.040204.144452
   PubMedGoogle Scholar
• Clark, T., Chandrasekhar, J., Spitznagel, G. W., & Schleyer, P. V. R. (1983). Efficient diffuse function-augmented basis sets for anion calculations. III. The 3-21 + G basis set for first-row elements, Li-F. Journal of Computational Chemistry, 4(3), 294–301. https://doi.org/10.1002/jcc.540040303
   Web of Science ®Google Scholar
• de Smedt, E., Devin, J., Muylaert, C., Robert, N., Requirand, G., Vlummens, P., Vincent, L., Cartron, G., Maes, K., Moreaux, J., & de Bruyne, E. (2021). G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death. Blood Advances, 5(9), 2325–2338. https://doi.org/10.1182/bloodadvances.2020003217
   PubMed Web of Science ®Google Scholar
• Epsztejn-Litman, S., Feldman, N., Abu-Remaileh, M., Shufaro, Y., Gerson, A., Ueda, J., Deplus, R., Fuks, F., Shinkai, Y., Cedar, H., & Bergman, Y. (2008). De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nature Structural & Molecular Biology, 15(11), 1176–1183. https://doi.org/10.1038/nsmb.1476
   PubMed Web of Science ®Google Scholar
• Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. Journal of Chemical Physics, 103(19), 8577–8593. https://doi.org/10.1063/1.470117
   Web of Science ®Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G. A., Nakatsuji, H., Caricato, M., Li, X., Hratchian, H. P., Izmaylov, A. F., Bloino, J., Zheng, G., Sonnenberg, J. L., Hada, M., … Fox, D. J. (2009). Gaussian 09, revision E.01. Gaussian.
   Google Scholar
• Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., & Overington, J. P. (2012). ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Research, 40(Database issue), D1100–D1107. https://doi.org/10.1093/nar/gkr777
   PubMed Web of Science ®Google Scholar
• Gelato, K. A., & Fischle, W. (2008). Role of histone modifications in defining chromatin structure and function. Biological Chemistry, 389(4), 353–363. https://doi.org/10.1515/BC.2008.048
   PubMed Web of Science ®Google Scholar
• Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. https://doi.org/10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E., & Imhof, A. (2005). Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nature Chemical Biology, 1(3), 143–145. https://doi.org/10.1038/nchembio721
   PubMed Web of Science ®Google Scholar
• Grewal, S. I. S., & Moazed, D. (2003). Heterochromatin and epigenetic control of gene expression. Science (New York, N.Y.), 301(5634), 798–802. https://doi.org/10.1126/science.1086887
   PubMed Web of Science ®Google Scholar
• Griñán-Ferré, C., Marsal-García, L., Bellver-Sanchis, A., Kondengaden, S. M., Turga, R. C., Vázquez, S., & Pallàs, M. (2019). Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer’s disease mouse model. Aging, 11(23), 11591–11608. https://doi.org/10.18632/aging.102558
   PubMedGoogle Scholar
• Güner, O. F. (2002). History and evolution of the pharmacophore concept in computer-aided drug design. Current Topics in Medicinal Chemistry. 2, 1321–1332. https://doi.org/10.2174/1568026023392940
   PubMedGoogle Scholar
• Halim, S. A., Waqas, M., Asim, A., Khan, M., Khan, A., & Al-Harrasi, A. (2022). Discovering novel inhibitors of P2Y12 receptor using structure-based virtual screening, molecular dynamics simulation and MMPBSA approaches. Computers in Biology and Medicine, 147, 105743. https://doi.org/10.1016/j.compbiomed.2022.105743
   PubMed Web of Science ®Google Scholar
• Han, J. L. T., Pang, K. K. L., Ang, S. R. X., Sharma, M., & Sajikumar, S. (2021). Inhibition of lysine methyltransferase G9a/GLP reinstates long-term synaptic plasticity and synaptic tagging/capture by facilitating protein synthesis in the hippocampal CA1 area of APP/PS1 mouse model of Alzheimer’s disease. Translational Neurodegeneration, 10(1), 23. https://doi.org/10.1186/s40035-021-00247-0
   PubMed Web of Science ®Google Scholar
• Hoover, W. G. (1985). Canonical dynamics: Equilibrium phase-space distributions. Physical Review. A, General Physics, 31(3), 1695–1697. https://doi.org/10.1103/PhysRevA.31.1695
   PubMedGoogle Scholar
• Huang, J., Dorsey, J., Chuikov, S., Zhang, X., Jenuwein, T., Reinberg, D., & Berger, S. L. (2010). G9a and Glp methylate lysine 373 in the tumor suppressor p53. The Journal of Biological Chemistry, 285(13), 9636–9641. https://doi.org/10.1074/jbc.M109.062588
   PubMed Web of Science ®Google Scholar
• Humphreys, D. D., Friesner, R. A., & Berne, B. J. (1994). A multiple-time-step molecular dynamics algorithm for macromolecules. The Journal of Physical Chemistry, 98(27), 6885–6892. https://doi.org/10.1021/j100078a035
   Web of Science ®Google Scholar
• Jacobson, M. P., Friesner, R. A., Xiang, Z., & Honig, B. (2002). On the role of the crystal environment in determining protein side-chain conformations. Journal of Molecular Biology, 320(3), 597–608. https://doi.org/10.1016/S0022-2836(02)00470-9
   PubMed Web of Science ®Google Scholar
• Jana, A., Naga, R., Saha, S., & Banerjee, D. R. (2022a). 3D QSAR pharmacophore based lead identification of G9a lysine methyltransferase towards epigenetic therapeutics. Journal of Biomolecular Structure and Dynamics, 1–19. https://doi.org/10.1080/07391102.2022.2135600
   Google Scholar
• Jana, A., Roy, T., Layek, S., Ghosal, S., & Banerjee, D. R. (2022b). Computational investigation on natural quinazoline alkaloids as potential inhibitors of the main protease (Mpro) of SARS-CoV-2. Journal of Computational Biophysics and Chemistry, 21(01), 65–82. https://doi.org/10.1142/S2737416522500053
   Google Scholar
• Jenuwein, T., & Allis, C. D. (2001). Translating the histone code. Science (New York, N.Y.), 293(5532), 1074–1080. https://doi.org/10.1126/science.1063127
   PubMed Web of Science ®Google Scholar
• Jin, W.-Y., Ma, Y., Li, W.-Y., Li, H.-L., & Wang, R.-L. (2018). Scaffold-based novel SHP2 allosteric inhibitors design using receptor-ligand pharmacophore model, virtual screening and molecular dynamics. Computational Biology and Chemistry, 73, 179–188. https://doi.org/10.1016/j.compbiolchem.2018.02.004
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. Journal of Chemical Physics. 79(2), 926–935. https://doi.org/10.1063/1.445869
   Web of Science ®Google Scholar
• Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996). Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. Journal of the American Chemical Society, 118(45), 11225–11236. https://doi.org/10.1021/ja9621760
   Web of Science ®Google Scholar
• Kaniskan, H. Ü., & Jin, J. (2015). Chemical probes of histone lysine methyltransferases. ACS Chemical Biology, 10(1), 40–50. https://doi.org/10.1021/cb500785t
   PubMed Web of Science ®Google Scholar
• Kaniskan, H. Ü., Martini, M. L., & Jin, J. (2018). Inhibitors of protein methyltransferases and demethylases. Chemical Reviews, 118(3), 989–1068. https://doi.org/10.1021/acs.chemrev.6b00801
   PubMed Web of Science ®Google Scholar
• Katayama, K., Ishii, K., Terashima, H., Tsuda, E., Suzuki, M., Yotsumoto, K., Hiramoto, K., Yasumatsu, I., Torihata, M., Ishiyama, T., Muto, T., & Katagiri, T. (2021). Discovery of DS79932728: A potent, orally available G9a/GLP inhibitor for treating β-thalassemia and sickle cell disease. ACS Medicinal Chemistry Letters, 12(1), 121–128. https://doi.org/10.1021/acsmedchemlett.0c00572
   PubMed Web of Science ®Google Scholar
• Katayama, K., Ishii, K., Tsuda, E., Yotsumoto, K., Hiramoto, K., Suzuki, M., Yasumatsu, I., Igarashi, W., Torihata, M., Ishiyama, T., & Katagiri, T. (2020). Discovery of novel histone lysine methyltransferase G9a/GLP (EHMT2/1) inhibitors: Design, synthesis, and structure-activity relationships of 2,4-diamino-6-methylpyrimidines. Bioorganic & Medicinal Chemistry Letters, 30(20), 127475. https://doi.org/10.1016/J.BMCL.2020.127475
   PubMed Web of Science ®Google Scholar
• Kondo, Y., Shen, L., Ahmed, S., Boumber, Y., Sekido, Y., Haddad, B. R., & Issa-Pierre, J. I. (2008). Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS One, 3(4), e2037. https://doi.org/10.1371/journal.pone.0002037
   PubMed Web of Science ®Google Scholar
• Koska, J., Spassov, V. Z., Maynard, A. J., Yan, L., Austin, N., Flook, P. K., & Venkatachalam, C. M. (2008). Fully automated molecular mechanics based induced fit protein − ligand docking method. Journal of Chemical Information and Modeling, 48(10), 1965–1973. https://doi.org/10.1021/ci800081s
   PubMed Web of Science ®Google Scholar
• Kouzarides, T. (2007). Chromatin modifications and their function. Cell, 128(4), 693–705. https://doi.org/10.1016/j.cell.2007.02.005
   PubMed Web of Science ®Google Scholar
• Krammer, A., Kirchhoff, P. D., Jiang, X., Venkatachalam, C. M., & Waldman, M. (2005). LigScore: A novel scoring function for predicting binding affinities. Journal of Molecular Graphics & Modelling, 23(5), 395–407. https://doi.org/10.1016/j.jmgm.2004.11.007
   PubMed Web of Science ®Google Scholar
• Krishnan, R., Binkley, J. S., Seeger, R., & Pople, J. A. (1980). Self‐consistent molecular orbital methods. XX. A basis set for correlated wave functions. Journal of Chemical Physics, 72(1), 650–654. https://doi.org/10.1063/1.438955
   Web of Science ®Google Scholar
• Kubicek, S., O'Sullivan, R. J., August, E. M., Hickey, E. R., Zhang, Q., Teodoro, M. L., Rea, S., Mechtler, K., Kowalski, J. A., Homon, C. A., Kelly, T. A., & Jenuwein, T. (2007). Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Molecular Cell, 25(3), 473–481., https://doi.org/10.1016/j.molcel.2007.01.017
   PubMed Web of Science ®Google Scholar
• Kuhn, B., Gerber, P., Schulz-Gasch, T., & Stahl, M. (2005). Validation and use of the MM-PBSA approach for drug discovery. Journal of Medicinal Chemistry, 48(12), 4040–4048. https://doi.org/10.1021/jm049081q
   PubMed Web of Science ®Google Scholar
• Leung, D. C., Dong, K. B., Maksakova, I. A., Goyal, P., Appanah, R., Lee, S., Tachibana, M., Shinkai, Y., Lehnertz, B., Mager, D. L., Rossi, F., & Lorincz, M. C. (2011). Lysine methyltransferase G9a is required for de novo DNA methylation and the establishment, but not the maintenance, of proviral silencing. Proceedings of the National Academy of Sciences of the United States of America, 108(14), 5718–5723. https://doi.org/10.1073/pnas.1014660108
   PubMed Web of Science ®Google Scholar
• Lin, C.-H., Chang, T.-T., Sun, M.-F., Chen, H.-Y., Tsai, F.-J., Chang, K.-L., Fisher, M., & Chen, C. Y.-C. (2011). Potent inhibitor design against H1N1 swine influenza: Structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database. Journal of Biomolecular Structure & Dynamics, 28(4), 471–482. https://doi.org/10.1080/07391102.2011.10508589
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1-3), 3–26. https://doi.org/10.1016/s0169-409x(00)00129-0
   PubMed Web of Science ®Google Scholar
• Liu, F., Barsyte-Lovejoy, D., Allali-Hassani, A., He, Y., Herold, J. M., Chen, X., Yates, C. M., Frye, S. V., Brown, P. J., Huang, J., Vedadi, M., Arrowsmith, C. H., & Jin, J. (2011). Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines. Journal of Medicinal Chemistry, 54(17), 6139–6150. https://doi.org/10.1021/jm200903z
   PubMed Web of Science ®Google Scholar
• Liu, F., Chen, X., Allali-Hassani, A., Quinn, A. M., Wasney, G. A., Dong, A., Barsyte, D., Kozieradzki, I., Senisterra, G., Chau, I., Siarheyeva, A., Kireev, D. B., Jadhav, A., Herold, J. M., Frye, S. V., Arrowsmith, C. H., Brown, P. J., Simeonov, A., Vedadi, M., & Jin, J. (2009). Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. Journal of Medicinal Chemistry, 52(24), 7950–7953. https://doi.org/10.1021/jm901543m
   PubMed Web of Science ®Google Scholar
• Liu, F., Chen, X., Allali-Hassani, A., Quinn, A. M., Wigle, T. J., Wasney, G. A., Dong, A., Senisterra, G., Chau, I., Siarheyeva, A., Norris, J. L., Kireev, D. B., Jadhav, A., Herold, J. M., Janzen, W. P., Arrowsmith, C. H., Frye, S. V., Brown, P. J., Simeonov, A., Vedadi, M., & Jin, J. (2010). Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines. Journal of Medicinal Chemistry, 53(15), 5844–5857. https://doi.org/10.1021/jm100478y
   PubMed Web of Science ®Google Scholar
• Ma, D.-L., Chan, D. S.-H., & Leung, C.-H. (2011). Molecular docking for virtual screening of natural product databases. Chemical Science, 2(9), 1656–1665. https://doi.org/10.1039/C1SC00152C
   Web of Science ®Google Scholar
• Manhas, A., Kumar, S., & Jha, P. C. (2022). Identification of the natural compound inhibitors against Plasmodium falciparum plasmepsin-II via common feature based screening and molecular dynamics simulations. Journal of Biomolecular Structure & Dynamics, 40(1), 31–43. https://doi.org/10.1080/07391102.2020.1806110
   PubMed Web of Science ®Google Scholar
• Martin, C., & Zhang, Y. (2005). The diverse functions of histone lysine methylation. Nature Reviews. Molecular Cell Biology, 6(11), 838–849. https://doi.org/10.1038/nrm1761
   PubMed Web of Science ®Google Scholar
• Martyna, G. J., Tobias, D. J., & Klein, M. L. (1994). Constant pressure molecular dynamics algorithms. Journal of Chemical Physics. 101(5), 4177–4189. https://doi.org/10.1063/1.467468
   Web of Science ®Google Scholar
• Moreira-Silva, F., Outeiro-Pinho, G., Lobo, J., Guimarães, R., Gaspar, V. M., Mano, J. F., Agirre, X., Pineda-Lucena, A., Prosper, F., Paramio, J. M., Henrique, R., Correia, M. P., & Jerónimo, C. (2022). G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 150, 113031. https://doi.org/10.1016/j.biopha.2022.113031
   PubMed Web of Science ®Google Scholar
• Opo, F. A. D. M., Rahman, M. M., Ahammad, F., Ahmed, I., Bhuiyan, M. A., & Asiri, A. M. (2021). Author correction: Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein. Scientific Reports, 11(1), 19106. https://doi.org/10.1038/s41598-021-97945-6
   PubMed Web of Science ®Google Scholar
• Pal, S., Kumar, V., Kundu, B., Bhattacharya, D., Preethy, N., Reddy, M. P., & Talukdar, A. (2019). Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase I inhibitors. Computational and Structural Biotechnology Journal, 17, 291–310. https://doi.org/10.1016/j.csbj.2019.02.006
   PubMed Web of Science ®Google Scholar
• Peng, J., Li, Y., Zhou, Y., Zhang, L., Liu, X., & Zuo, Z. (2018). Pharmacophore modeling, molecular docking and molecular dynamics studies on natural products database to discover novel skeleton as non-purine xanthine oxidase inhibitors. Journal of Receptor and Signal Transduction Research, 38(3), 246–255. https://doi.org/10.1080/10799893.2018.1476544
   PubMed Web of Science ®Google Scholar
• Puthanveedu, V., & Muraleedharan, K. (2022). Phytochemicals as potential inhibitors for COVID-19 revealed by molecular docking, molecular dynamic simulation and DFT studies. Structural Chemistry, 33(5), 1423–1443. https://doi.org/10.1007/s11224-022-01982-4
   PubMed Web of Science ®Google Scholar
• Raafat, A., Mowafy, S., Abouseri, S., M., Fouad, M. A., & Farag, N. A. (2022). Lead generation of cysteine based mesenchymal epithelial transition (c-Met) kinase inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulation. Computers in Biology and Medicine, 146, 105526. https://doi.org/10.1016/j.compbiomed.2022.105526
   PubMed Web of Science ®Google Scholar
• Ramya Chandar Charles, M., Hsieh, H.-P., & Selvaraj Coumar, M. (2019). Delineating the active site architecture of G9a lysine methyltransferase through substrate and inhibitor binding mode analysis: a molecular dynamics study. Journal of Biomolecular Structure & Dynamics, 37(10), 2581–2592. https://doi.org/10.1080/07391102.2018.1491422
   PubMed Web of Science ®Google Scholar
• Ramya Chandar Charles, M., Li, M.-C., Hsieh, H.-P., & Coumar, M. S. (2021). Mimicking H3 substrate arginine in the design of G9a lysine methyltransferase inhibitors for cancer therapy: A computational study for structure-based drug design. ACS Omega, 6(9), 6100–6111. https://doi.org/10.1021/acsomega.0c04710
   PubMed Web of Science ®Google Scholar
• Ramya Chandar Charles, M., Mahesh, A., Lin, S.-Y., Hsieh, H.-P., Dhayalan, A., & Coumar, M. S. (2020). Identification of novel quinoline inhibitor for EHMT2/G9a through virtual screening. Biochimie, 168, 220–230. https://doi.org/10.1016/j.biochi.2019.11.006
   PubMed Web of Science ®Google Scholar
• Sakkiah, S., Arullaperumal, V., Hwang, S., & Lee, K. W. (2014). Ligand-based pharmacophore modeling and Bayesian approaches to identify c-Src inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 29(1), 69–80. https://doi.org/10.3109/14756366.2012.753881
   PubMed Web of Science ®Google Scholar
• Sakkiah, S., Thangapandian, S., John, S., Kwon, Y. J., & Lee, K. W. (2010). 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors. European Journal of Medicinal Chemistry, 45(6), 2132–2140. https://doi.org/10.1016/j.ejmech.2010.01.016
   PubMed Web of Science ®Google Scholar
• Salam, N. K., Nuti, R., & Sherman, W. (2009). Novel method for generating structure-based pharmacophores using energetic analysis. Journal of Chemical Information and Modeling, 49(10), 2356–2368. https://doi.org/10.1021/ci900212v
   PubMed Web of Science ®Google Scholar
• Sanchez, N. A., Kallweit, L. M., Trnka, M. J., Clemmer, C. L., & Al-Sady, B. (2021). Heterodimerization of H3K9 histone methyltransferases G9a and GLP activates methyl reading and writing capabilities. The Journal of Biological Chemistry, 297(5), 101276. https://doi.org/10.1016/j.jbc.2021.101276
   PubMed Web of Science ®Google Scholar
• Sepay, N., Mondal, R., Al-Muhanna, M. K., & Saha, D. (2022). Identification of natural flavonoids as novel EGFR inhibitors using DFT, molecular docking, and molecular dynamics. New Journal of Chemistry, 46(20), 9735–9744. https://doi.org/10.1039/D2NJ00389A
   Web of Science ®Google Scholar
• Sessions, Z., Sánchez-Cruz, N., Prieto-Martínez, F. D., Alves, V. M., Santos, H. P., Muratov, E., Tropsha, A., & Medina-Franco, J. L. (2020). Recent progress on cheminformatics approaches to epigenetic drug discovery. Drug Discovery Today, 25(12), 2268–2276. https://doi.org/10.1016/j.drudis.2020.09.021
   PubMed Web of Science ®Google Scholar
• Shivanika, C., Deepak Kumar, S., Ragunathan, V., Tiwari, P., Sumitha, A., & Brindha Devi, P. (2022). Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease. Journal of Biomolecular Structure & Dynamics, 40(2), 585–611. https://doi.org/10.1080/07391102.2020.1815584
   PubMed Web of Science ®Google Scholar
• Singh, R., Bhardwaj, V. K., Das, P., Bhattacherjee, D., Zyryanov, G. V., & Purohit, R. (2022). Benchmarking the ability of novel compounds to inhibit SARS-CoV-2 main protease using steered molecular dynamics simulations. Computers in Biology and Medicine, 146, 105572. https://doi.org/10.1016/j.compbiomed.2022.105572
   PubMed Web of Science ®Google Scholar
• Sirous, H., Campiani, G., Calderone, V., & Brogi, S. (2021). Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening. Computers in Biology and Medicine, 137, 104808. https://doi.org/10.1016/j.compbiomed.2021.104808
   PubMed Web of Science ®Google Scholar
• Sorokina, M., Merseburger, P., Rajan, K., Yirik, M. A., & Steinbeck, C. (2021). COCONUT online: Collection of open natural products database. Journal of Cheminformatics, 13(1), 2. https://doi.org/10.1186/s13321-020-00478-9
   PubMed Web of Science ®Google Scholar
• Spassov, V. Z., Yan, L., & Flook, P. K. (2007). The dominant role of side-chain backbone interactions in structural realization of amino acid code. ChiRotor: A side-chain prediction algorithm based on side-chain backbone interactions. Protein Science: A Publication of the Protein Society, 16(3), 494–506. https://doi.org/10.1110/ps.062447107
   PubMed Web of Science ®Google Scholar
• Srimongkolpithak, N., Sundriyal, S., Li, F., Vedadi, M., & Fuchter, M. J. (2014). Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors. Medchemcomm, 5(12), 1821–1828. https://doi.org/10.1039/C4MD00274A
   PubMed Web of Science ®Google Scholar
• Strahl, B. D., & Allis, C. D. (2000). The language of covalent histone modifications. Nature, 403(6765), 41–45. https://doi.org/10.1038/47412
   PubMed Web of Science ®Google Scholar
• Sutter, J., Li, J., Maynard, A. J., Goupil, A., Luu, T., & Nadassy, K. (2011). New features that improve the pharmacophore tools from Accelrys. Current Computer-Aided Drug Design, 7(3), 173–180. https://doi.org/10.2174/157340911796504305
   PubMed Web of Science ®Google Scholar
• Sweis, R. F., Pliushchev, M., Brown, P. J., Guo, J., Li, F., Maag, D., Petros, A. M., Soni, N. B., Tse, C., Vedadi, M., Michaelides, M. R., Chiang, G. G., & Pappano, W. N. (2014). Discovery and development of potent and selective inhibitors of histone methyltransferase G9a. ACS Medicinal Chemistry Letters, 5(2), 205–209. https://doi.org/10.1021/ml400496h
   PubMed Web of Science ®Google Scholar
• Tanwar, G., Mazumder, A. G., Bhardwaj, V., Kumari, S., Bharti, R., Damanpreet Singh, Y., Das, P., & Purohit, R. (2019). Target identification, screening and in vivo evaluation of pyrrolone-fused benzosuberene compounds against human epilepsy using Zebrafish model of pentylenetetrazol-induced seizures. Scientific Reports, 9(1), 7904. https://doi.org/10.1038/s41598-019-44264-6
   PubMedGoogle Scholar
• Thangapandian, S., John, S., Sakkiah, S., & Lee, K. W. (2010). Ligand and structure based pharmacophore modeling to facilitate novel histone deacetylase 8 inhibitor design. European Journal of Medicinal Chemistry, 45(10), 4409–4417. https://doi.org/10.1016/j.ejmech.2010.06.024
   PubMed Web of Science ®Google Scholar
• Thangapandian, S., John, S., Sakkiah, S., & Lee, K. W. (2011). Potential virtual lead identification in the discovery of renin inhibitors: Application of ligand and structure-based pharmacophore modeling approaches. European Journal of Medicinal Chemistry, 46(6), 2469–2476. https://doi.org/10.1016/j.ejmech.2011.03.035
   PubMed Web of Science ®Google Scholar
• Thienpont, B., Aronsen, J. M., Robinson, E. L., Okkenhaug, H., Loche, E., Ferrini, A., Brien, P., Alkass, K., Tomasso, A., Agrawal, A., Bergmann, O., Sjaastad, I., Reik, W., & Roderick, H. L. (2017). The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy. The Journal of Clinical Investigation, 127(1), 335–348. https://doi.org/10.1172/JCI88353
   PubMed Web of Science ®Google Scholar
• Vasilopoulou, F., Bellver-Sanchis, A., Companys-Alemany, J., Jarne-Ferrer, J., Irisarri, A., Palomera-Ávalos, V., Gonzalez-Castillo, C., Ortuño-Sahagún, D., Sanfeliu, C., Pallàs, M., & Griñán-Ferré, C. (2022). Cognitive decline and BPSD are concomitant with autophagic and synaptic deficits associated with G9a alterations in aged SAMP8 mice. Cells, 11(16), 2603. https://doi.org/10.3390/cells11162603
   PubMed Web of Science ®Google Scholar
• Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/10.1021/jm020017n
   PubMed Web of Science ®Google Scholar
• Vedadi, M., Barsyte-Lovejoy, D., Liu, F., Rival-Gervier, S., Allali-Hassani, A., Labrie, V., Wigle, T. J., DiMaggio, P. A., Wasney, G. A., Siarheyeva, A., Dong, A., Tempel, W., Wang, S.-C., Chen, X., Chau, I., Mangano, T. J., Huang, X., Simpson, C. D., Pattenden, S. G., … Jin, J. (2011). A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nature Chemical Biology, 7(8), 566–574. https://doi.org/10.1038/nchembio.599
   PubMed Web of Science ®Google Scholar
• Vilhais-Neto, G. C., Fournier, M., Plassat, J.-L., Sardiu, M. E., Saraf, A., Garnier, J.-M., Maruhashi, M., Florens, L., Washburn, M. P., & Pourquié, O. (2017). The WHHERE coactivator complex is required for retinoic acid-dependent regulation of embryonic symmetry. Nature Communications, 8(1), 728. https://doi.org/10.1038/s41467-017-00593-6
   PubMedGoogle Scholar
• Watanabe, H., Soejima, K., Yasuda, H., Kawada, I., Nakachi, I., Yoda, S., Naoki, K., & Ishizaka, A. (2008). Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells. Cancer Cell International, 8(1), 15. https://doi.org/10.1186/1475-2867-8-15
   PubMedGoogle Scholar
• Wu, G., Robertson, D. H., Brooks, C. L., & Vieth, M. (2003). Detailed analysis of grid-based molecular docking: A case study of CDOCKER? A CHARMm-based MD docking algorithm. Journal of Computational Chemistry, 24(13), 1549–1562. https://doi.org/10.1002/jcc.10306
   PubMed Web of Science ®Google Scholar
• Xiong, Y., Li, F., Babault, N., Dong, A., Zeng, H., Wu, H., Chen, X., Arrowsmith, C. H., Brown, P. J., Liu, J., Vedadi, M., & Jin, J. (2017a). Discovery of potent and selective inhibitors for G9a-like protein (GLP) lysine methyltransferase. Journal of Medicinal Chemistry, 60(5), 1876–1891. https://doi.org/10.1021/ACS.JMEDCHEM.6B01645/SUPPL_FILE/JM6B01645_SI_001.PDF
   PubMed Web of Science ®Google Scholar
• Xiong, Y., Li, F., Babault, N., Wu, H., Dong, A., Zeng, H., Chen, X., Arrowsmith, C. H., Brown, P. J., Liu, J., Vedadi, M., & Jin, J. (2017b). Structure-activity relationship studies of G9a-like protein (GLP) inhibitors. Bioorganic & Medicinal Chemistry, 25(16), 4414–4423. https://doi.org/10.1016/j.bmc.2017.06.021
   PubMed Web of Science ®Google Scholar
• Yang, Q., Zhu, Q., Lu, X., Du, Y., Cao, L., Shen, C., Hou, T., Li, M., Li, Z., Liu, C., Wu, D., Xu, X., Wang, L., Wang, H., Zhao, Y., Yang, Y., & Zhu, W.-G. (2017). G9a coordinates with the RPA complex to promote DNA damage repair and cell survival. Proceedings of the National Academy of Sciences, 114(30), E6054-E6063. https://doi.org/10.1073/pnas.1700694114
   Web of Science ®Google Scholar
• Yankulov, K. (2015). Book review: Epigenetics (second edition, eds. Allis, Caparros, Jenuwein, Reinberg). Frontiers in Genetics, 6, 315. https://doi.org/10.3389/fgene.2015.00315
   Google Scholar
• Zhang, Z., & Pugh, B. F. (2011). High-resolution genome-wide mapping of the primary structure of chromatin. Cell, 144(2), 175–186. https://doi.org/10.1016/j.cell.2011.01.003
   PubMed Web of Science ®Google Scholar
• Zhong, S., Hou, Y., Zhang, Z., Guo, Z., Yang, W., Dou, G., Lv, X., Wang, X., Ge, J., Wu, B., Pan, X., Wang, H., Yang, Q., & Mou, Y. (2022). Identification of novel natural inhibitors targeting AKT serine/threonine kinase 1 (AKT1) by computational study. Bioengineered, 13(5), 12003–12020. https://doi.org/10.1080/21655979.2021.2011631
   PubMed Web of Science ®Google Scholar